Idra stock news
IDRA / Idera Pharmaceuticals, Inc. 10-K - Annual Report - 10-K. 03-12 sec.gov - 1 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 … Idera Pharmaceuticals (NasdaqCM:IDRA) - Share price, News ... In this section, we usually try to help investors determine whether . Idera Pharmaceuticals is trading at an attractive price based on the cash flow it is expected to produce in the future.. But as Idera Pharmaceuticals has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data IDRA Idera Pharmaceuticals, Inc. Stock Quote Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for oncology in the United States. It offers Tilsotolimod, a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors
IDRA Stock Price Quote & News - Idera Pharmaceuticals ...
Find recent news headlines for a specific symbol on this page. Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. Idera Pharmaceuticals, Inc. - IDRA - Stock Price Today - Zacks View Idera Pharmaceuticals, Inc. IDRA investment & stock information. Get the latest Idera Pharmaceuticals, Inc. IDRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Idera Pharmaceuticals Inc., IDRA Quick Chart - (NAS) IDRA ...
Apr 01, 2020 · Idera Pharmaceuticals, Inc. (IDRA) reported on March 11, 2020 its financial and operational results for the fourth quarter and year ended December 31, 2019. In 2019, we made great progress with ILLUMINATE-301, our registrational trial of tilsotolimod in combination with ipilimumab in anti-PD-1 refractory patients with advanced melanoma.
Idera Pharmaceuticals, Inc. - TheStreet Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
View the real-time IDRA price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Idera Pharmaceuticals against related stocks people have also bought like VKTX, INO, RIGL, and SCYX. 1,695 people own Idera Pharmaceuticals on Robinhood on April 3, 2020.
IDRA:NASDAQ CM Stock Quote - Idera Pharmaceuticals Inc ... Stock analysis for Idera Pharmaceuticals Inc (IDRA:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. IDRA News Today (Idera Pharmaceuticals) | MarketBeat
Idera Pharmaceuticals, Inc. (IDRA) Stocktalk | Seeking Alpha
IDRA Stock Price | Idera Pharmaceuticals Inc. Stock Quote ... IDRA | Complete Idera Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Idera Pharmaceuticals, Inc. (IDRA) Stock Price, Quote ... Find the latest Idera Pharmaceuticals, Inc. (IDRA) stock quote, history, news and other vital information to help you with your stock trading and investing. Idera Pharmaceuticals, Inc. Common Stock (IDRA) News ...
Looking for insights on Idera (NCM:IDRA) stock? View IDRA's stock ratings, price targets, earnings, commentary and news at Smarter Analyst. Idera Pharmaceuticals - Idera Pharmaceuticals Idera Pharmaceuticals Completes Enrollment in ILLUMINATE-301, its Registrational Trial of Tilsotolimod in Combination with Ipilimumab in Patients with Anti-PD-1 Refractory Advanced Melanoma. Overall Response Rate (ORR) Data Anticipated Q1 2021 EXTON, Pa. , …